Trial Profile
Retrospective study of Leronlimab in covid19 infections
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2021
Price :
$35
*
At a glance
- Drugs Leronlimab (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 08 Mar 2021 New trial record
- 01 Feb 2021 Results published in the International Journal of Infectious Diseases